calcineurin inhibitor tacrolimus topical
Selected indexed studies
- Atopic Dermatitis: Diagnosis and Treatment. (Am Fam Physician, 2020) [PMID:32412211]
- Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. (J Allergy Clin Immunol, 2023) [PMID:37678572]
- Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis. (Lancet Child Adolesc Health, 2023) [PMID:36370744]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Oral lichen planus: comparative efficacy and treatment costs-a systematic review. (2022) pubmed
- Atopic Dermatitis: Diagnosis and Treatment. (2020) pubmed
- Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. (2023) pubmed
- Topical Tacrolimus in Anterior Segment Disorders in Ophthalmology: A Review. (2024) pubmed
- Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis. (2023) pubmed
- ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. (2020) pubmed
- Interventions for treating oral lichen planus: corticosteroid therapies. (2020) pubmed
- Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. (2018) pubmed
- Efficacy and Safety of Topical Tacrolimus in Comparison with Topical Corticosteroids, Calcineurin Inhibitors, Retinoids and Placebo in Oral Lichen Planus: An Updated Systematic Review and Meta-Analysis. (2023) pubmed
- Topical Calcineurin Inhibitors and Skin Cancer-Another Piece of the Puzzle. (2020) pubmed